Works matching IS 09024441 AND DT 2023 AND VI 110 AND IP 2

Results: 17

The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission—A retrospective multicenter study.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 149, doi. 10.1111/ejh.13884

By:

Shargian, Liat;
Amit, Odelia;
Bernstine, Hanna;
Gurion, Ronit;
Gafter‐Gvili, Anat;
Rozovski, Uri;
Pasvolsky, Oren;
Perets, Galit;
Horowitz, Netanel A.;
Halloun, Jabour;
Perry, Chava;
Avivi, Irit;
Raanani, Pia;
Yeshurun, Moshe;
Ram, Ron

Publication type:

Article

Phenotype of BTK‐lacking myeloid cells during prolonged COVID‐19 and upon convalescent plasma.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 209, doi. 10.1111/ejh.13881

By:

Gomes, André M. C.;
Farias, Guilherme B.;
Trombetta, Amelia C.;
Godinho‐Santos, Ana;
Parreira, Inês;
Gonçalves, Hélder Diogo;
Simões, Mariana Lessa;
Aguiar, Patrício;
Deveza, Maria Manuel;
Inácio, João;
Sousa, Ana E.;
da Silva, Susana Lopes

Publication type:

Article

Efficacy of venetoclax plus anti‐CD38 monoclonal antibody‐containing therapies among t(11;14) positive multiple myeloma patients regardless of timing of prior treatment with this antibody.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 222, doi. 10.1111/ejh.13896

By:

Regidor, Bernard Sean;
Siddiqi, Dilawer;
Beatty, Bethany Marie;
Goldwater, Marissa‐Skye;
Jew, Scott;
Bujarski, Sean;
Swift, Regina;
Kim, Susanna;
Berenson, James R.

Publication type:

Article

High expression of AP2M1 correlates with worse prognosis by regulating immune microenvironment and drug resistance to R‐CHOP in diffuse large B cell lymphoma.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 198, doi. 10.1111/ejh.13895

By:

Liu, Xindi;
Zhao, Xiaoli;
Yang, Jing;
Wang, Henan;
Piao, Yingshi;
Wang, Liang

Publication type:

Article

Individualized busulfan dosing improves outcomes compared to fixed‐dose administration in pre‐transplant minimal residual disease‐positive acute myeloid leukemia patients with intermediate‐risk undergoing allogeneic stem cell transplantation in CR

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 188, doi. 10.1111/ejh.13893

By:

Klyuchnikov, Evgeny;
Langebrake, Claudia;
Badbaran, Anita;
Dadkhah, Adrin;
Massoud, Radwan;
Freiberger, Petra;
Ayuk, Francis;
Janson, Dietlinde;
Wolschke, Christine;
Bacher, Ulrike;
Kröger, Nicolaus

Publication type:

Article

Clearance of bone marrow mast cells after hypomethylating agent and venetoclax for systemic mastocytosis associated with myeloid neoplasia.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 213, doi. 10.1111/ejh.13894

By:

Pourhassan, Hoda;
Kim, Young;
Pullarkat, Vinod

Publication type:

Article

The role of oral iron in the treatment of adults with iron deficiency.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 123, doi. 10.1111/ejh.13892

By:

Lo, Jamie O.;
Benson, Ashley E.;
Martens, Kylee L.;
Hedges, Madeline A.;
McMurry, Hannah Stowe;
DeLoughery, Thomas;
Aslan, Joseph E.;
Shatzel, Joseph J.

Publication type:

Article

Outcomes of coronavirus disease 2019 (COVID‐19) and risk factors associated with severe COVID‐19 in patients with mature B‐cell non‐Hodgkin lymphomas: A US electronic health record cohort study.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 177, doi. 10.1111/ejh.13891

By:

Yue, Xiaomeng;
Hallett, David;
Liu, Yangyang;
Basa, Elisa;
McNeill, Annie;
Dean, James P.

Publication type:

Article

Management of polycythemia vera: A survey of treatment patterns in Italy.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 161, doi. 10.1111/ejh.13889

By:

Palumbo, Giuseppe Alberto;
Breccia, Massimo;
Baratè, Claudia;
Bonifacio, Massimiliano;
Elli, Elena Maria;
Iurlo, Alessandra;
Pugliese, Novella;
Rossi, Elena;
Guglielmelli, Paola;
Palandri, Francesca

Publication type:

Article

Real‐world utility of early measurable residual disease assessments by multi‐parametric flow cytometry in adult patients with B‐lymphoblastic leukemia receiving Hyper‐CVAD induction chemotherapy.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 168, doi. 10.1111/ejh.13890

By:

Nedumannil, Rithin;
Ritchie, David;
Bajel, Ashish;
Ng, Ashley P.;
Harrison, Simon J.;
Westerman, David

Publication type:

Article

Response to Caravita di Toritto and Rago.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 224, doi. 10.1111/ejh.13887

By:

Chaireti, Roza;
Uttervall, Katarina;
Luong, Vincent;
Lund, Johan;
Kashif, Muhammad;
Gahrton, Gösta;
Alici, Evren;
Nahi, Hareth;
Afram, Gabriel

Publication type:

Article

Response to "Conditioning with melphalan (Mel) 200 mg/m<sup>2</sup> and subsequent autologous stem cell transplantation improves progression free survival and overall survival in elderly multiple myeloma patients compared to standard of care".

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 221, doi. 10.1111/ejh.13888

By:

Caravita di Toritto, Tommaso;
Rago, Angela

Publication type:

Article

IDH2<sup>R172</sup> mutation in angioimmunoblastic T‐cell lymphoma: A retrospective multicenter case series.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 217, doi. 10.1111/ejh.13885

By:

Riva, Marcello;
Tisi, Maria Chiara;
Bertorelle, Roberta;
Famengo, Barbara;
D'Amore, Emanuele Stefano Giovanni;
Pizzi, Marco;
Parisi, Alice;
Boscato, Elena;
Mazzucco, Maddalena;
Semenzato, Gianpietro;
Krampera, Mauro;
Gherlinzoni, Filippo;
Trentin, Livio;
Ruggeri, Marco;
Visco, Carlo;
Stefani, Piero Maria;
Piazza, Francesco

Publication type:

Article

Preemptive cyclosporin A in immune‐mediated thrombotic thrombocytopenic purpura.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 157, doi. 10.1111/ejh.13886

By:

Comparon, Celine;
Galicier, Lionel;
Rebibou, Jean Michel;
Coppo, Paul;
Benhamou, Ygal

Publication type:

Article

Issue Information.

Published in:: European Journal of Haematology, 2023, v. 110, n. 2, p. 121, doi. 10.1111/ejh.13792
Publication type:: Article

Cytogenetic and molecular characteristics and outcomes of adult patients with early T‐cell precursor acute lymphoblastic leukemia.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 137, doi. 10.1111/ejh.13883

By:

Yoon, Jae‐Ho;
Kim, Hoon Seok;
Min, Gi June;
Park, Sung‐Soo;
Park, Silvia;
Lee, Sung‐Eun;
Cho, Byung‐Sik;
Eom, Ki‐Seong;
Kim, Yoo‐Jin;
Kim, Hee‐Je;
Min, Chang‐Ki;
Cho, Seok‐Goo;
Lee, Jong Wook;
Kim, Myungshin;
Kim, Yonggoo;
Lee, Seok

Publication type:

Article

Non‐driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia.

Published in:

European Journal of Haematology, 2023, v. 110, n. 2, p. 131, doi. 10.1111/ejh.13882

By:

Morishita, Soji;
Hashimoto, Yoshinori;
Furuya, Chiho;
Edahiro, Yoko;
Ochiai, Tomonori;
Shirane, Shuichi;
Inano, Tadaaki;
Yasuda, Hajime;
Ando, Miki;
Araki, Marito;
Komatsu, Norio

Publication type:

Article